Skip to main content
Log in

Tyrosinemia type I: Case series with response to treatment to NTBC

  • Case Series
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

We present four children with tyrosinemia and their response to NTBC [2-[2-nitro-4-trifluoromethylbenzoyl]-1, 3-cyclohexanedione]. One child received NTBC for only 3 months after which he was diagnosed to have hepatocellular carcinoma and underwent a living-related liver transplantation. The child is doing well post-transplant. Remaining three children have been on NTBC for almost 3 years, have normal liver functions, undetectable urine succinylacetone, and no portal hypertension or renal tubular acidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kitagawa T. Hepatorenal tyrosinemia. Proceedings of the Japan Academy. Series B. Phys Biol Sci. 2012;88:192–200.

    CAS  Google Scholar 

  2. Sakai K, Kitagawa T. An atypical case of tyrosinosis [l-para-hydroxyphenyllactic aciduria] part 1. Clinical and laboratory findings. Jikeikai Med J. 1957;4:1–10.

    CAS  Google Scholar 

  3. Shah I. Tyrosinemia: a report of three cases from India. Indian J Gastroenterol. 2013;32:123–6.

    Article  PubMed  Google Scholar 

  4. Raimann E, Cornejo V, Arias C, et al. Clinical follow up of Chilean patients with tyrosinemia type 1 treated with 2-[2-nitro-4-trifluoromethylbenzoyl]-1,3-ciclohexanedione [NTBC]. Rev Med Chil. 2012;140:169–75.

    Article  CAS  PubMed  Google Scholar 

  5. Noble-Jamieson G, Jamieson N, Clayton P, Bailey S, Ryalls M, Barnes ND. Neurological crisis in hereditary tyrosinaemia and complete reversal after liver transplantation. Arch Dis Child. 1994;70:544–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sniderman King L, Trahms C, Scott CR. Tyrosinemia Type I. 2006 Jul 24 [Updated 2014 Jul 17]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle [WA]: University of Washington, Seattle; 1993–2015. http://www.ncbi.nlm.nih.gov/books/NBK1515.

  7. Physician’s Guide to Tyrosinemia Type 1. NORD. http://rarediseases.org/rare-diseases/tyrosinemia-type-1. Accessed on 1st June 2015.

  8. Mayorandan S, Meyer U, Gokcay G, et al. Cross-sectional study of 168 patients with hepatorenal tyrosinemia and implications for clinical practice. Orphanet J Rare Dis. 2014;9:107.

    Article  PubMed  PubMed Central  Google Scholar 

  9. de Laet C, Dionisi-Vici C, Leonard JV, et al. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis. 2013;8:8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mieles LA, Esquivel CO, Van Thiel DH, et al. Liver transplantation for tyrosinemia: a review of 10 cases from the University of Pittsburgh. Dig Dis Sci. 1990;35:153–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ira Shah.

Ethics declarations

Conflict of interest

IS, and FS declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shah, I., Shah, F. Tyrosinemia type I: Case series with response to treatment to NTBC. Indian J Gastroenterol 35, 229–231 (2016). https://doi.org/10.1007/s12664-016-0650-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-016-0650-3

Keywords

Navigation